Translational

Biomarker Discovery

Decoding the disease fingerprint

Excelra’s innovative in silico biomarker discovery platform facilitates the integration and analysis of patient-centric multi-omics, clinical and biomedical data; towards early identification of novel disease biomarkers.

Our biomarker discovery solutions empower:

  • Rapid disease diagnosis
  • Prediction of prognosis, drug-resistance, and patient response
  • Development of personalized medicine strategies

Drug Repositioning

A new lease of life for the drug

With the sky-rocketing costs, high risk and prolonged duration of de novo drug development, drug repositioning has emerged as a prudent path wherein, drugs with proven safety are used to treat diseases with unmet therapeutic needs.

Drug Repositioning (DR) at Excelra is driven by our proprietary Global Repurposing Integrated Platform (GRIP) that channels large volumes of data from in-house and public databases, into advanced analytics pipelines. We expedite cost-effective rescue and repurposing of drugs that are shelved, failed, in-development, or even approved; towards new indications. Our DR solutions empower accelerated drug development and portfolio expansion.

icon

Drug-Disease-Target
Centric Approaches

icon

Biological Insights

icon

Novel Drug Combinations

icon

Reformulation & Route of
Administration Strategies

icon

Veterinary DR

Systems Biology Informatics

Connecting the dots to discover custom cures

As new in-roads are being forged into exploring disease origins, it has become evident that there exists a profound biological interconnectedness, which demands a holistic view of health and illness.

Our integrated systems approach empowers the massively parallel deconstruction of complex, multiscale disease networks. By comprehensively elucidating the causal biological drivers of disease, we enable targeted therapy innovations across indications, to improve outcomes.

At Excelra, we make this happen with our collaborative intelligence models that synergize big biomedical data, with the sheer power of data science analytics and expert scientific minds.

Biology Curation Services

Immense data to intelligent decisions

Ground-breaking advances in myriad domains of the biopharma space have led to the generation of big data that mainly lies unstructured and dispersed.

Excelra’s biology curation services encompass the custom curation and data analytics of the vast universe of biomedical knowledge. We provide innovative solutions for our partners in data mining and harmonization, targeted literature curation, and scientific visualization through custom-built applications. Leveraging our expert scientific pool, we can adequately address complex scientific questions to accelerate cost-effective drug development.

Our customized solutions include:

icon

Actionable mutations for targeted therapy

icon

Clinical genome variant interpretation & reporting

icon

Gene set enrichment analysis & pathway analysis

icon

Text mining & analysis of clinical trial data

icon

Gene & Biological process annotation-ontology mapping

icon

Phenotype reporting-outcome mapping

icon

Multi-omics data integration & analysis

icon

Off-label use of approved drugs

GOBIOM

Global Online Biomarker Database
Global Online Biomarker Database

Excelra’s GOBIOM, is the world’s largest manually curated database of validated and putative biomarkers, providing actionable insights into the biomarker-disease relationship.

GOBIOM delivers comprehensive pre-clinical and clinical biomarker intelligence integrated from diverse global sources; providing critical insights into diagnosis, prognosis, treatment-response, efficacy and toxicity.

Global Online Biomarker Database

Have a Question?